Categories: News

Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023

BOCA RATON, Fla., March 24, 2023 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the fourth quarter and full year ended December 31, 2022, before the market opens on Friday, March 31, 2023.

Management will host a conference call and audio webcast on Friday, March 31, 2023, at 8:00 a.m. ET to discuss the Company’s financial results.

Event: Fourth Quarter and Full Year 2022 Financial Results Conference Call
Date: Friday, March 31, 2023
Time: 8:00 a.m. Eastern Time
Live Call: 1-800-715-9871 (U.S. & Canada Toll-Free)
Conference ID 6955959
Webcast: Register

For interested individuals unable to join the conference call, a webcast of the call will be available for one year following the conference call and can be accessed via webcast on Jushi’s Investor Relations website.

About Jushi Holdings Inc.

We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, InstagramFacebookTwitter, and LinkedIn.

For further information, please contact:

Investor Relations
Lisa Forman
Director of Investor Relations
617-767-4419
investors@jushico.com

Media Contact
Ellen Mellody
MATTIO Communications
570-209-2947
jushi@mattio.com

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago